Riyadh – Mubasher: The extraordinary general meeting (EGM) of Dallah Healthcare Company has approved a 20% increase in share capital to be executed through the issuance of bonus shares.
The capital will rise from SAR 1 billion to SAR 1.21 billion. The expansion involves the issuance of 20.31 million new shares, increasing the total share count from 101.57 million to 121.88 million.
Shareholders will receive one bonus share for every five shares owned. The company stated the move aims to align its capital base with its total asset profile and strengthen its overall financial position.
The SAR 203.14 million increase will be funded by capitalizing SAR 93.61 million from the statutory reserve and SAR 109.53 million from the share premium account.
Eligibility for the bonus shares is set for shareholders registered at the end of the second trading day following the assembly date of 30 August 2026.
The meeting, which recorded a 76.57% attendance rate, saw 99.99746% of votes cast in favor of the capital hike.
Fractional shares will be consolidated and sold at market price, with proceeds distributed within 30 days of the eligibility determination.
Following the approval, the company will amend Articles 7 and 8 of its Bylaws to reflect the new capital structure.
